Dennis M Brown is Chief Scientific Officer of Kintara Therapeutics, Inc.. Currently has a direct ownership of 5,302 shares of KTRA, which is worth approximately $954. The most recent transaction as insider was on Jan 05, 2023, when has been sold 363 shares (Common Stock, par value $0.001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.3K
0% 3M change
0% 12M change
Total Value Held $954

Dennis M Brown Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 05 2023
BUY
Acquisition or disposition by will or laws
-
363 Added 6.41%
5,302 Common Stock, par valu...
Aug 01 2022
BUY
Grant, award, or other acquisition
-
240,087 Added 49.3%
246,905 Common Stock
Apr 29 2021
BUY
Conversion of derivative security
-
750 Added 9.91%
6,818 Common Stock
Apr 29 2021
BUY
Other acquisition or disposition
-
6 Added 0.1%
6,068 Common Stock
Mar 31 2021
BUY
Other acquisition or disposition
-
17 Added 0.28%
6,062 Common Stock
Dec 31 2020
BUY
Other acquisition or disposition
-
17 Added 0.28%
6,045 Common Stock
Sep 30 2020
BUY
Other acquisition or disposition
-
17 Added 0.28%
6,028 Common Stock

Also insider at

CLCS
Cell Source, Inc. Healthcare
DMB

Dennis M Brown

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on KTRA

Follow Kintara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTRA shares.

Notify only if

Insider Trading

Get notified when an Kintara Therapeutics, Inc. insider buys or sells KTRA shares.

Notify only if

News

Receive news related to Kintara Therapeutics, Inc.

Track Activities on KTRA